단일 세포 오믹스 시장 규모, 점유율, 성장 분석 : 기술별, 제품별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Single-Cell Omics Market size was valued at USD 4.82 Billion in 2024 and is poised to grow from USD 5.61 Billion in 2025 to USD 18.85 Billion by 2033, growing at a CAGR of 16.32% during the forecast period (2026-2033).

The global single-cell omics market is rapidly evolving, showcasing a range of advanced technologies designed to analyze genomes, transcriptomes, epigenomes, and proteomes at the individual cell level. This innovation addresses the need to reveal cellular heterogeneity often masked by traditional bulk assays, facilitating a deeper understanding of cell variations that can translate into significant clinical applications, such as identifying drug-resistant clones within tumor microenvironments and enhancing immune profiling for better checkpoint inhibitor therapies. Key advancements include the transition to high-throughput droplet sequencing and multimodal platforms. The decline in costs per sample has broadened accessibility for academia and industry alike, encouraging pharmaceutical investments. This trend supports the integration of single-cell profiling into fundamental biopharma operations, promoting advancements in diagnostics and personalized medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single-Cell Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single-Cell Omics Market Segments Analysis

Global single-cell omics market is segmented by technology, product, application, end-user and region. Based on technology, the market is segmented into single-cell genomics, single-cell transcriptomics (scRNA-seq), single-cell proteomics and single-cell epigenomics. Based on product, the market is segmented into instruments, reagents & kits and software & bioinformatics. Based on application, the market is segmented into oncology, immunology, neuroscience and developmental biology. Based on end-user, the market is segmented into research institutes, pharma & biotech and CROs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Single-Cell Omics Market

The rapid advancement of single-cell sequencing technologies, microfluidics, and imaging methods has significantly enhanced the accessibility and sensitivity of single-cell omics workflows. This progress allows researchers to investigate individual cells more confidently, reducing technical challenges, boosting sample throughput, and broadening the scope of biological inquiries. As these capabilities improve and the quality of reagents rises, there is an anticipated increase in stakeholder investment in single-cell solutions. This heightened interest is expected to propel market growth, driven by rising demand for various systems, consumables, and services across academic, clinical, and industrial sectors.

Restraints in the Global Single-Cell Omics Market

The considerable financial investment required for cutting-edge single-cell sequencing equipment, specialized microfluidic technologies, and premium reagents poses a significant obstacle for various laboratories and clinical environments. Ongoing expenses related to consumables and instrument upkeep can strain the budgets of smaller research institutions and those located in developing regions. These economic limitations hinder the pace of adoption, often leading to a preference for centralized service models rather than broader in-house implementation. Consequently, market growth is stifled as potential customers choose to delay or bypass purchases, opting instead for shared facilities or external service providers to meet their needs.

Market Trends of the Global Single-Cell Omics Market

The Global Single-Cell Omics market is witnessing a surge in demand fueled by the growing adoption of integrated multi-omics workflows. Researchers and biopharma companies are increasingly seeking comprehensive solutions that encompass single-cell genomics, transcriptomics, proteomics, and epigenomics, enabling deeper biological insights while minimizing sample loss. This shift is prompting vendors to innovate by creating interoperable instruments and standardized reagents, facilitating complex experimental designs and cross-modal data interpretation. Additionally, enhanced collaboration between technology developers and application scientists is accelerating translational research, significantly impacting drug discovery, diagnostics, and precision medicine initiatives, thereby reshaping the landscape of biomedical research.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Single-cell Omics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Single-Cell Genomics
• Single-Cell Transcriptomics (scRNA-seq)
• Single-Cell Proteomics
• Single-Cell Epigenomics

Global Single-cell Omics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits
• Software & Bioinformatics

Global Single-cell Omics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Immunology
• Neuroscience
• Developmental Biology

Global Single-cell Omics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Research Institutes
• Pharma & Biotech
• CROs

Global Single-cell Omics Market Size & CAGR (2026-2033)

• North America (Technology, Product, Application, End-User)
  • US
  • Canada
• Europe (Technology, Product, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parse Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vizgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singlera Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mission Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellenics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curio Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scale Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Honeycomb Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singular Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspect Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berry Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations